Veterinary pharmaceutical firm Hipra is launching the one dose presentation of Eravac, the primary monovalent vaccine to be registered in Europe for the prevention of rabbit haemorrhagic illness kind 2 (RHD-2) for pet rabbits.
This single-dose presentation has been authorised by the European Medicines Company, with pet rabbits included within the indications as a goal species.
Eravac is an injectable emulsion prepared for administration with out the necessity for reconstitution beforehand. Containing 10 vials with particular person doses, Eravac can be utilized for lively immunisation of pet rabbits from 30 days of age.
Hipra might be showcasing Eravac at London Vet Present on 15 and 16 November.